Skip to main content Back to Top


Epinephrine Injection

Products Affected - Description

    • Epinephrine injection, Amphastar, 0.1 mg/mL, 10 mL syringe, 10 count, NDC 76329-3316-01
    • Epinephrine injection, Pfizer, 0.1 mg/mL, 10 mL 20 gauge Luer Lock syringe, 10 count, NDC 00409-4933-01

Reason for the Shortage

    • Amphastar has epinephrine available. Their epinephrine is still a grandfathered product.[1]
    • Pfizer has recently received FDA approval for their epinephrine 0.1 mg/mL 10 mL syringes. These have had a recent NDC change since the previous product was a grandfathered item.[2]
    • BPI has epinephrine 1 mg/mL 2 mL ampules available.[3]
    • Par has Adrenalin 1 mg/mL 1 mL and 30 mL vials available.[4]

Available Products

    • Adrenalin injection, Par Sterile Products, 1 mg/mL, 1 mL vial, 25 count, NDC 42023-0159-25
    • Adrenalin injection, Par Sterile Products, 1 mg/mL, 30 mL multiple dose vial, 1 count, NDC 42023-0168-01
    • Epinephrine injection, Amphastar, 1 mg/mL, 30 mL vial, 1 count, NDC 76329-9060-00
    • Epinephrine injection, BPI Labs, 1 mg/mL, 2 mL containing 1 mL sulfite-free and preservative-free ampule, 10 count, NDC 54288-0103-10

Estimated Resupply Dates

    • Amphastar has epinephrine 0.1 mg/mL 10 mL syringes on allocation with regular weekly releases.[1]
    • Pfizer has epinephrine 0.1 mg/mL 10 mL Luer-Lock syringes available in limited supply.[2]

Implications for Patient Care

    • Epinephrine emergency syringes are commonly used for treatment of ventricular fibrillation or pulseless ventricular tachycardia unresponsive to initial defibrillatory shocks, pulseless electrical activity, and asystole.[5-6]


    • Epinephrine is a high alert medication and may cause significant patient harm when used in error.[6]
    • Create a dose conversion chart reflecting available epinephrine concentrations to keep in code boxes and post in areas where epinephrine is frequently used.[7]
    • Do not stock the 30 mL multi-dose vials in code boxes.[7]
    • Routine bulk compounding is not an option due to epinephrine having a short stability time and sensitivity to pH, light, and air.[7]

Alternative Agents & Management

    • Consider conserving current supplies of epinephrine emergency syringes for code boxes or code situations.
    • Consider limiting the number of emergency syringes that are stocked in the code boxes.[7]


    1. Amphastar (personal communications). May 3 and 30, 2017; April 26, August 12, 2019; April 29, July 21 and 31, December 14, 2020; June 1, and December 13, 2021.
    2. Pfizer (personal communications and website). May 3 and 26, June 2 and 14, July 6, August 4 and 28, September 29, November 7 and 15, December 1 and 8, 2017; January 6, February 9 and 20, March 9, May 11, June 29, August 10 and 30, September 28, November 1, December 7, 2018; January 31, March 1 and 29, April 26, May 31, June 3, August 30, September 13, November 1, December 3, 2019; January 3, February 20, March 27, July 20 and 31, August 28, December 11, 2020; March 10, May 28, December 3, 2021; and March 25, 2022.
    3. BPI Labs. May 3 2017.
    4. Par Pharmaceuticals. May 3, and June 12, 2017; and January 24, 2018.
    5. Epinephrine Injection product information. Lake Forest, IL: Hospira; 2016 March.
    6. Epinephrine. Lexi-Comp Online. Hudson, OH: Lexi-Comp Inc.; 2017.
    7. Institute for Safe Medication Practices. EPINEPHrine pre-filled syringe shortage. . Accessed May 31, 2017.


Updated March 30, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 4, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.



Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.